Strs Ohio Gilead Sciences, Inc. Transaction History

Strs Ohio

$24.7 Billion
Q1 2024

A detailed history of Strs Ohio transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 544,702 shares of GILD stock, worth $37.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

544,702

Previous 596,747 8.72%

Holding current value

$37.3 Million

Previous $48.3 Million 17.47%

% of portfolio

0.16%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $3.73 Million - $4.54 Million	-52,045 Reduced 8.72%	544,702 $39.9 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $2.37 Million - $2.69 Million	-32,316 Reduced 5.14%	596,747 $48.3 Million
Q3 2023 Oct 26, 2023	SELL	$73.94 - $80.67 $1.8 Million - $1.97 Million	-24,399 Reduced 3.73%	629,063 $47.1 Million
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $2.74 Million - $3.12 Million	-36,015 Reduced 5.22%	653,462 $50.4 Million
Q1 2023 Aug 02, 2023	BUY	$77.31 - $88.08 $2.78 Million - $3.17 Million	36,015 Added 5.51%	689,477 $57.2 Million

Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $426,828 - $486,289	5,521 Added 0.81%	689,477 $57.2 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $1.72 Million - $2.48 Million	-27,672 Reduced 3.89%	683,956 $58.7 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $43,523 - $49,715	731 Added 0.1%	711,628 $43.9 Million
Q2 2022 Jul 25, 2022	SELL	$57.72 - $65.01 $1.4 Million - $1.58 Million	-24,241 Reduced 3.3%	710,897 $43.9 Million
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $538,424 - $674,703	9,296 Added 1.28%	735,138 $43.7 Million
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $591,640 - $671,523	-9,119 Reduced 1.24%	725,842 $52.7 Million
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $1.02 Million - $1.1 Million	-14,995 Reduced 2.0%	734,961 $51.3 Million
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $3.25 Million - $3.56 Million	51,263 Added 7.34%	749,956 $51.6 Million
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $4.23 Million - $4.83 Million	70,487 Added 11.22%	698,693 $45.2 Million
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $1.42 Million - $1.62 Million	-25,105 Reduced 3.84%	628,206 $36.6 Million
Q3 2020 Dec 14, 2020	SELL	$62.1 - $78.08 $2.94 Million - $3.7 Million	-47,392 Reduced 6.76%	653,311 $41.3 Million
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $3.12 Million - $3.62 Million	43,143 Added 6.56%	700,703 $53.9 Million
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $15.5 Million - $19.8 Million	-247,314 Reduced 27.33%	657,560 $49.2 Million
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $2.68 Million - $2.95 Million	-43,451 Reduced 4.58%	904,874 $58.8 Million
Q3 2019 Oct 21, 2019	SELL	$62.51 - $69.0 $570,028 - $629,211	-9,119 Reduced 0.95%	948,325 $60.1 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $4.96 Million - $5.56 Million	80,171 Added 9.14%	957,444 $64.7 Million
Q1 2019 Apr 19, 2019	SELL	$62.53 - $70.05 $222,044 - $248,747	-3,551 Reduced 0.4%	877,273 $57 Million
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $312,689 - $408,035	5,165 Added 0.59%	880,824 $55.1 Million
Q3 2018 Oct 19, 2018	SELL	$71.28 - $78.92 $4.09 Million - $4.52 Million	-57,333 Reduced 6.15%	875,659 $67.6 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $692,139 - $807,354	10,668 Added 1.16%	932,992 $66.1 Million
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $31.9 Million - $38.8 Million	-437,296 Reduced 32.16%	922,324 $69.5 Million
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $3.78 Million - $4.43 Million	-53,070 Reduced 3.76%	1,359,620 $97.4 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $102 Million - $121 Million	1,412,690	1,412,690 $114 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account